Anti-Spike Antibody Responses in Hemodialyzed Patients Vaccinated with Anti-COVID-19 BNT162b2 mRNA Vaccine

被引：0
|
作者：
Godinho, Iolanda [1 ]
Abrantes, Ana Rita [1 ]
Bergman, Marie-Louise L. [2 ]
Goncalves, Ligia A. [2 ]
Duarte, Nadia [2 ]
Borges, Patricia C. [2 ]
Brennand, Ana [2 ]
Malheiro, Vanessa C. [2 ]
Matoso, Paula G. [2 ]
Akpogheneta, Onome [2 ]
Demengeot, Jocelyne [2 ]
Penha-Goncalves, Carlos [2 ]
Marques, Marco A. [3 ]
Nogueira, Estela [1 ]
Cruz, Pedro A. [1 ]
Weigert, Andre L. [1 ]
机构：
[1] Davita Obidos, Obidos, Portugal
[2] Inst Gulbenkian Ciencias, Oeiras, Portugal
[3] Affidea Portugal, Lisbon, Portugal
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO0135
引用
收藏
页码：96 / 96
页数：1
相关论文
共 50 条
  • [21] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
    Dagan, Noa
    Barda, Noam
    Biron-Shental, Tal
    Makov-Assif, Maya
    Key, Calanit
    Kohane, Isaac S.
    Hernan, Miguel A.
    Lipsitch, Marc
    Hernandez-Diaz, Sonia
    Reis, Ben Y.
    Balicer, Ran D.
    NATURE MEDICINE, 2021, 27 (10) : 1693 - +
  • [22] Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy
    Cosan, Fulya
    Demirel, Ozlem Unay
    Yalcin, Demet
    Sonkaya, Muhammed Mert
    Uluisik, Isilsu Ezgi
    Cecen, Olida
    Furuncuoglu, Yavuz
    Celikmen, Deniz Maktav
    Kara, Osman
    Ceylan, Erkan
    Avsar, Timucin
    BMC RHEUMATOLOGY, 2023, 7 (01)
  • [23] Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy
    Giossi, Riccardo
    Consonni, Alessandra
    Clerici, Valentina Torri
    Zito, Antonio
    Rigoni, Eleonora
    Antozzi, Carlo
    Brambilla, Laura
    Crisafulli, Sebastiano Giuseppe
    Bellino, Antonella
    Frangiamore, Rita
    Bonanno, Silvia
    Vanoli, Fiammetta
    Ciusani, Emilio
    Corsini, Elena
    Andreetta, Francesca
    Baggi, Fulvio
    Tramacere, Irene
    Mantegazza, Renato
    Conte, Antonella
    Bergamaschi, Roberto
    Confalonieri, Paolo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 58
  • [24] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
    Noa Dagan
    Noam Barda
    Tal Biron-Shental
    Maya Makov-Assif
    Calanit Key
    Isaac S. Kohane
    Miguel A. Hernán
    Marc Lipsitch
    Sonia Hernandez-Diaz
    Ben Y. Reis
    Ran D. Balicer
    Nature Medicine, 2021, 27 : 1693 - 1695
  • [25] BNT162b2 mRNA COVID-19 Vaccine: First Approval
    Lamb, Yvette N.
    DRUGS, 2021, 81 (04) : 495 - 501
  • [26] Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine
    Lopez-Valle, Alba
    Falkenhain-Lopez, Daniel
    Arranz, Celia R.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (07) : 891 - 892
  • [27] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Polack, Fernando P.
    Thomas, Stephen J.
    Kitchin, Nicholas
    Absalon, Judith
    Gurtman, Alejandra
    Lockhart, Stephen
    Perez, John L.
    Perez Marc, Gonzalo
    Moreira, Edson D.
    Zerbini, Cristiano
    Bailey, Ruth
    Swanson, Kena A.
    Roychoudhury, Satrajit
    Koury, Kenneth
    Li, Ping
    Kalina, Warren V.
    Cooper, David
    Frenck, Robert W., Jr.
    Hammitt, Laura L.
    Tureci, Ozlem
    Nell, Haylene
    Schaefer, Axel
    Unal, Serhat
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27): : 2603 - 2615
  • [28] Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy
    Fulya Cosan
    Ozlem Unay Demirel
    Demet Yalcin
    Muhammed Mert Sonkaya
    Isilsu Ezgi Uluisik
    Olida Cecen
    Yavuz Furuncuoglu
    Deniz Maktav Celikmen
    Osman Kara
    Erkan Ceylan
    Timucin Avsar
    BMC Rheumatology, 7
  • [29] IgG anti-spike antibody levels in healthcare workers with and without prior COVID-19 up to 3 months after BNT162b2 vaccination
    Van Elslande, Jan
    Weemaes, Matthias
    Godderis, Lode
    Van Pottelbergh, Gijs
    Bossuyt, Xavier
    Vermeersch, Pieter
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2022, 102 (04)
  • [30] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Wang, Xiang
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1577 - 1578
12345